Elevated C-reactive protein (CRP) levels are associated with an increased risk of developing type 2 diabetes in middle-aged men independently of established risk factors,
Read More »Diabetes In Control
Issue 111 Item 15 Globesity’ 22 Million Children Worldwide are Overweight or Obe
Weaknesses in the science behind the BMI, because it does not distinguish between fat mass and lean mass.
Read More »Issue 107 Item 3 Ibuprofen – Blocks Aspirin Benefits – Alert
Ibuprofen may hinder aspirin’s heart-helping ways. The results of a new study suggest that the painkiller ibuprofen may undermine aspirin’s proven blood-thinning effects, which can protect against heart disease and stroke
Read More »Issue 109 Item 1 Education Helps Reduce Elevated Glycosylated Hemoglobin Levels
A trial comparing intensive and passive education in patients with diabetes.
Read More »Issue 111 Item 4 ADA: Insulin Patch May Help Dodge the Needle
A 24-hour insulin patch to provide painless, needle-free, basal insulin delivery for people with diabetes coming closer.
Read More »Issue 108 Item 7 AACE: Combination Therapy Best For Diabetics With Higher Glycem
First line treatment of glyburide and metformin found to be safe and effective with synergistic results.
Read More »Issue 110 Item 5 ADA: Oralin as a Meal Insulin in Treatment of Type-2 Diabetes
RapidMist, a novel buccal diabetes rapid insulin delivery device.
Read More »Issue 107 Item 13 Growing Diabetes Epidemic, it Deserves Respect
U.S. HEALTH SYSTEM FUELS GROWING DIABETES EPIDEMIC. Doctors need to “wake up” if they think serious complications of diabetes are inevitable in minority patients.
Read More »Issue 109 Item 11 Cardiac Events Increased With High-Normal BP
Framingham study finding
Read More »Issue 111 Item 14 ACC, AHA, NHLBI Clinical Advisory Confirms Safety, Effectivene
Joint Advisory Reassures Physicians, Patients About Drugs’ Importance in Lowering Cholesterol
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.